← Leaderboards
Matthew Gordon Sampson
University Of Michigan At Ann Arbor
$7,198,497
Attributed
$13,245,650
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.5M · FY2013–25$2.5M$1.9M$1.3M$625K$0
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$13,245,650 · 4
By mechanism
RC2$7,447,539 · 1
R01$5,338,031 · 2
K08$460,080 · 1
Top collaborators
- Simone Sanna-Cherchi8 shared
- Friedhelm Hildebrandt7 shared
- Martin R. Pollak7 shared
Most similar at University Of Michigan At Ann Arbor
Same institution · by research overlap
- Matthias Kretzler$40,447,062
- Thomas G Robins$10,229,414
- Lawrence B. Holzman$27,704,361
- William E. Smoyer$10,448,587
- Friedhelm Hildebrandt$22,945,432
Others in their field
Top investigators on “Genetic Variant”
- Richard A Gibbs · Baylor College Of Medicine$370,015,672
- Richard K. Wilson · Washington University$221,917,930
- Stacey Gabriel · Massachusetts Institute Of Technology$134,153,706
- David Heimbrook · Leidos Biomedical Research, Inc.$117,485,565
- Eric A Boerwinkle · University Of Texas Hlth Sci Ctr Houston$86,197,161
- Margaret A Pericak-Vance · Doheny Eye Institute$84,831,559
Research focus
Genetic VariantVariantAffectNephrotic SyndromeGenesGeneticKidneyCohortAllelesBiologyPhenotypeKidney DiseasesGenomicsGenotypePrevalenceGenome-WideClassificationLeadResponseFocal Segmental GlomerulosclerosisAmericanGene ExpressionData SetCells
Grant awards (22)
APOL1 - associated nephropathy from human-derived, intrarenal perspective$922,998
R01 · FY2025 · DK · contact PI
Integrating large scale genomics and functional studies to accelerate FSGS/NS discovery$1,399,415
RC2 · FY2024 · DK
Integrating large scale genomics and functional studies to accelerate FSGS/NS discovery$53,362
RC2 · FY2024 · DK
Integrating large scale genomics and functional studies to accelerate FSGS/NS discovery$26,682
RC2 · FY2024 · DK
Integrating large scale genomics and functional studies to accelerate FSGS/NS discovery$1,466,058
RC2 · FY2023 · DK
Whole Genome Sequencing for Nephrotic Syndrome Discovery$564,946
R01 · FY2023 · DK · contact PI
Integrating large scale genomics and functional studies to accelerate FSGS/NS discovery$1,474,145
RC2 · FY2022 · DK
Whole Genome Sequencing for Nephrotic Syndrome Discovery$561,214
R01 · FY2022 · DK · contact PI
Integrating large scale genomics and functional studies to accelerate FSGS/NS discovery$1,482,000
RC2 · FY2021 · DK
Whole Genome Sequencing for Nephrotic Syndrome Discovery$559,912
R01 · FY2021 · DK · contact PI
Integrating large scale genomics and functional studies to accelerate FSGS/NS discovery$1,545,877
RC2 · FY2020 · DK
Whole Genome Sequencing for Nephrotic Syndrome Discovery$552,820
R01 · FY2020 · DK · contact PI
APOL1-associated nephropathy from a human-derived, intrarenal perspective$356,551
R01 · FY2020 · DK · contact PI
Whole Genome Sequencing for Nephrotic Syndrome Discovery$566,487
R01 · FY2019 · DK · contact PI
APOL1-associated nephropathy from a human-derived, intrarenal perspective$196,063
R01 · FY2019 · DK · contact PI
APOL1-associated nephropathy from a human-derived, intrarenal perspective$113,776
R01 · FY2019 · DK · contact PI
APOL1-associated nephropathy from a human-derived, intrarenal perspective$309,838
R01 · FY2018 · DK · contact PI
APOL1-associated nephropathy from a human-derived, intrarenal perspective$314,465
R01 · FY2017 · DK · contact PI
APOL1-associated nephropathy from a human-derived, intrarenal perspective$318,961
R01 · FY2016 · DK · contact PI
An Integrative Systems Genetics Approach to Nephrotic Syndrome$153,360
K08 · FY2015 · DK · contact PI
An Integrative Systems Genetics Approach to Nephrotic Syndrome$153,360
K08 · FY2014 · DK · contact PI
An Integrative Systems Genetics Approach to Nephrotic Syndrome$153,360
K08 · FY2013 · DK · contact PI